Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026)

Revolution Medicines' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $14.5 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 10.26% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $14.5 million (up 10.26% YoY), while the FY2025 annual figure was $14.8 million, up 748.39% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $14.5 million, down from $14.8 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $14.9 million in Q3 2025, with the low at $725000.0 in Q2 2022.
• The 5-year median for Other Non-Current Assets is $3.0 million (2024), against an average of $6.0 million.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets soared 1226.17% in 2023, then plunged 75.23% in 2024.
• Revolution Medicines' Other Non-Current Assets stood at $2.9 million in 2022, then soared by 146.13% to $7.0 million in 2023, then slumped by 75.23% to $1.7 million in 2024, then surged by 748.39% to $14.8 million in 2025, then dropped by 2.03% to $14.5 million in 2026.
• Business Quant data shows RVMD's Other Non-Current Assets at $14.5 million in Q1 2026, $14.8 million in Q4 2025, and $14.9 million in Q3 2025.